Effect of Renal Impairment on Evobrutinib Pharmacokinetics (PK)
Clinical trial NCT03436394 · COMPLETED
Trial details
- NCT number
- NCT03436394
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-21
- Primary completion
- 2019-02-22
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.